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Sex Differences in the Effects of Testosterone and Its Metabolites on 
Vasopressin Messenger RNA Levels in the Bed Nucleus of the Stria 
Terminalis of Rats 
Geert J. De Vries, Zuoxin Wang, Nina A. Bullock, and Suzanne Numan 
Department of Psychology and Neuroscience and Behavior Program, University of Massachusetts, Amherst, 
Massachusetts 01003 
Male rats have about two times as many steroid-responsive 
vasopressin-immunoreactive (AVP-ir) neurons in the bed nu- 
cleus of the stria terminalis (BST) as female rats. This sex 
difference does not depend on differences in circulating hor- 
mone levels, since it persists in males and females that are 
treated with similar levels of testosterone. To analyze the 
cellular basis of this sex difference, we compared the effects 
of testosterone and its metabolites on AVP mRNA expres- 
sion in the BST of males and females that were gonadec- 
tomized at 3 months of age. 
When rats received implants of Silastic tubing filled with 
testosterone, males had more cells that were labeled for 
AVP mRNA and more labeling per cell than females. When, 
in a second experiment, rats received implants of either 
empty tubing, or tubing with dihydrotestosterone (DHT), es- 
tradiol (E), or E plus DHT, hardly any labeled cells were found 
in rats with empty implants. E treatment significantly stim- 
ulated AVP mRNA expression in both sexes, but significantly 
more so in males, which had more cells that were labeled 
for AVP mRNA and more labeling per cell than females. DHT 
treatment by itself did not stimulate AVP mRNA expression, 
but when given in combination with E, it significantly in- 
creased the number of cells over that of animals treated with 
E alone. This increase was seen in males only. However, in 
both sexes, it increased the labeling per cell over that of 
animals treated with E only, but more so in males than in 
females. These data suggest that in addition to a sex dif- 
ference in the number of cells that produce AVP there is 
also a sex difference in estrogen as well as androgen re- 
sponsiveness in individual AVP-producing cells in the BST. 
[Key words: vasopressin, testosterone, estradiol, dihyciro- 
testosterone, aromatase, sexual dimorphism] 
In rodents, gonadal hormone levels determine the direction of 
sexual differentiation of centrally regulated functions and be- 
haviors presumably by targeting specific neuronal systems in a 
restricted, critical period around birth. Indeed, many structural 
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sex differences have been found in the brain that depend on the 
sex differences in gonadal steroid levels during development 
(Yahr, 1988; De Vries, 1990; Breedlove, 1992). An example of 
such a system is the vasopressin-immunoreactive (AVP-ir) pro- 
jections of the bed nucleus of the stria terminalis (BST) to brain 
areas such as the lateral septum and lateral habenular nucleus. 
These projections are about twice as dense in males as in females 
(De Vries et al., 198 1; De Vries and Al-Shamma, 1990) and, 
correspondingly, the BST in males contains about two times as 
many AVP-ir cells, or cells that can be labeled for AVP mRNA 
as the BST in females (Van Leeuwen et al., 1985; Miller et al., 
1989b). The sex differences in AVP immunostaining of the BST 
projections remain present even when males and females are 
treated equally with testosterone (De Vries and Al-Shamma, 
1990). 
Although the development of this sex difference depends on 
the presence of gonadal steroids shortly after birth (Wang et al., 
1993) it is unclear specifically which cellular features underlie 
the expression of this difference. In addition to sex differences 
in the absolute number of cells that can produce AVP, these 
cells may differ in their responsiveness to gonadal hormones. 
After gonadectomy, BST cells lose their AVP immunoreactivity 
and can no longer be labeled for AVP mRNA unless the rats 
were treated with testosterone (De Vries et al., 1984, 1985; Van 
Leeuwen et al., 1985; Miller et al., 1989a, 1992). This effect of 
testosterone appears to depend on androgen as well as estrogen 
receptor-mediated mechanisms. Estradiol (E)-which is an es- 
trogenic metabolite of testosterone generated by aromatization 
(Naftolin et al., 1975)-partially restores AVP immunostaining 
in castrated male rats, while Sa-dihydrotestosterone (DHT)- 
which is an androgenic, nonaromatizable metabolite of testos- 
terone generated by reduction (Lieberburg and McEwen, 1975)- 
does not by itself restore AVP immunostaining. However, if 
DHT is given in combination with E, it enhances AVP im- 
munostaining (De Vries et al., 1986). Since male rats have higher 
levels ofaromatase, the enzyme that catalyzes the aromatization 
of testosterone into E, as well as higher numbers of androgen 
receptors in the BST than female rats (Roselli, 199 l), either of 
these difference might cause testosterone to stimulate BST cells 
more effectively in male than in female rats. To explore the 
possibility that sex differences in the effects of testosterone on 
AVP mRNA expression may be based on sex differences in the 
action of its metabolites, we compared the effects of testosterone 
and its metabolites E and DHT on AVP mRNA expression in 
the BST of male and female rats. 
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Materials and Methods 
In the first experiment, seven adult male and six adult female Long- 
Evans rats (80-90 d old) were gonadectomized and implanted with 
Silastic tubing (2.5 cm long, 1.5 mm id., 2.4 mm o.d.) filled with 
testosterone, which previously yielded plasma testosterone levels of 2.4- 
3.6 &ml, which is in the physiological range for males (De Vries et 
al., 1984). In the second experiment, adult male and female Long-Evans 
rats (80-90 d old) were gonadectomized and divided into four groups 
that received either empty implants (controls; seven males and seven 
females), or implants with Sol-dihydrotestosterone (DHT; six males and 
six females), estradiol (E; six males and eight females), and E plus DHT 
(E+DHT; six males and seven females). The dimensions of the Silastic 
tubing for E (1 cm long, 1 mm i.d., 2 mm o.d.) previously yielded 
plasma levels of 50-90 ne/ml E. which comnletelv suuuressed LH release 
in males, while the dim&sions used for DHT (3 cm, 1.5 mm and 2.4 
mm o.d.) previously yielded plasma levels of 0.9-l .8 rig/ml DHT, which 
fully restored the size of the seminal vesicles in castrated rats (De Vries 
et al., 1986). 
In both experiments, the animals were decapitated 4 weeks after 
receiving the implants. Their brains were removed, frozen on dry ice, 
and stored at - 80°C until they were cut in 25 pm sections with a cryostat. 
The sections were thaw mounted onto precleaned Superfrost/plus slides 
(Fisher), which were stored at -80°C until used. The in situ hybridiza- 
tion closely followed a procedure originally developed by Dr. Scott 
Young (Young et al., 1986) and modified by Drs. Dan Dorsa and Mar- 
garet Miller (Miller et al., 1992). Slides were postfixed in 4% parafor- 
maldehyde for 5 min and rinsed in 0.1 M phosphate-buffered saline (pH 
7.4) for 2 min, both at 4°C. The following incubations were done at 
room temperature: one rinse in 1.5% triethanolamine (TEA), an incu- 
bation in 0.25% acetic anhydride in TEA (pH 8.0) for 10 min, and two 
rinses with 0.03 M Na citrate in 0.3 M NaCl (2x SSC), pH 7.0. The 
sections were subsequently defatted in a graded ethanol series, 2 min 
each in 70%. 95%. and 100% ethanol: 5 min in chloroform: 2 min each 
in 100% and 95%‘ethanol, after which the sections were air dried. Each 
slide was placed horizontally and after applying 55 ~1 of hybridization 
solution, the slides were covered with silanized coverslips and placed 
in a humidified incubator for 14 hr at 37°C. For the first experiment, 
the hybridization solution contained 0.8 x lo6 dpm of an oligodeox- 
yribonucleotide antisense probe that contained 48 bases and was com- 
plementary to the AVP mRNA sequence coding for amino acids 129- 
144, which are located at the carboxyl end of the glycopeptide region 
of the AVP precursor peptide. For the second experiment it contained 
1.2 x lo6 dpm of the probe. The probe was labeled at the 3’-end with 
‘5S-dATP (New England Nuclear) using terminal deoxynucleotidyl 
transferase (Life Technologies Inc.), purified on a Nen-Sorb column 
(New England Nuclear), and heat denatured prior to mixing it with the 
rest of the hybridization buffer, which contained 50% formamide, 4 x 
SSC, 1 x Denhardt’s solution, 2.5 mg/ml yeast tRNA, 10% dextran 
sulfate (MW = SOO,OOO), 0.3 M NaCl, 10 mM Tris, and 10 mM di- 
thiothreitol. After incubation, the coverslips were removed by sub- 
mersing the slides in 1 x SSC, and the slides were rinsed 4 x 15 min 
in I x SSC at 55°C and 2 x 60 min in 1 x SSC at room temperature. 
The sections were then dehydrated through a graded series of 70%, 95%, 
and 100% ethanol and air dried. To reduce RNase activity, all solutions 
were prepared with sterile Hz0 that had been treated with 0.1% die- 
thylpyrocarbonate and autoclaved, and all glassware was baked at 250°C 
for 12 hr. Controls on the specificity included treating the sections with 
ribonuclease A (Sigma), which eliminated labeling; hybridizing sections 
with a sense probe, which did not produce any labeling; and rinsing the 
sections in 75°C and 9O”C, which greatly diminished and eliminated 
labeling, respectively. 
To locate the probe, the slides were dipped in Kodak NTB-2 track 
emulsion (1: 1 with 0.6 M ammonium acetate, pH 3.5) under safelight, 
and stored desiccated in light-tight boxes at 4°C. Four weeks later, the 
slides were developed with D19 (Kodak; 1: 1 with distilled water) and 
fixed with Kodak Rapid Fix, rinsed in distilled water followed by 0.1 
M Na acetate, pH 3.5, lightly counterstained with 0.2% cresyl violet in 
0.1 M acetate buffer, dehydrated with a graded ethanol series followed 
by xylene, and coverslipped. 
Sections were studied with a Zeiss Axioscope with a Darklite dark- 
field attachment (MicroVideo Instruments, Inc., Avon, MA). This at- 
tachment guides light from a central source via two fiber optic cables, 
which are flattened at the end to match the right- and left-hand ends of 
the slide. Because the light enters from the side, much of it is contained 
in the slide by total reflection and is only dispersed if it encounters silver 
grains. This gives a much brighter image of the silver grains than what 
can be obtained with a standard dark-field condenser. AVP mRNA- 
labeled cells were examined in 14 sections through the BST. Labeled 
cells were identified in dark-field illuminated slides, and only counted 
if bright-field illumination revealed a Nissl-stained cell and if the num- 
ber of grains was at least four times higher than background. For each 
subject and for each side of the brain, the number of AVP mRNA- 
labeled cells in the section with most labeled cells were used for data 
analysis. Grains were counted using dark-field illumination in the sec- 
tion that contained most AVP mRNA-labeled cells. Images of labeled 
cells were obtained with the 40 x objective and a CCD72 camera (Dage, 
MTI, Michigan City, IN) connected to a QuickCapture frame grabber 
board (Data Translation Inc., Marlboro, MA) in a Macintosh IIfx com- 
puter, and analyzed using the IMAGE version 1.44 program developed 
by Dr. Rasbaud from NIH, Bethesda, MD. The light intensity and 
camera setting were kept constant across the sections in order to stan- 
dardize measurements. Grains were counted by computerized gray-level 
thresholdinz (Shiolev et al.. 1989). which determined the number of 
pixels representing images ofgrainsin an area representing a circle with 
a diameter of 33 pm centered over the cell. The number of pixels was 
converted into number of grains using a linear regression curve that 
was obtained by correlating number of pixels with number of grains 
that were counted individually in 46 cells with grain counts ranging 
from 2 to 141. This gave a correlation coefficient of r = 0.99. The in 
situ hybridization and the analysis of the sections were done by exper- 
imenters that were blind to the identity of the specimens. 
The data were analyzed by a two-way analysis of variance (ANOVA) 
with sex as a between-subject variable and side of the brain as a repeated 
measure for the first experiment, and by a three-way ANOVA with sex 
and treatment as between-subject variables and side as a repeated mea- 
sure for the second experiment. Significant interactions of treatment 
and sex were further evaluated using the Newman Keuls post hoc test. 
Results 
Effects of testosterone on A VP mRNA in males and females 
After receiving similar implants of testosterone, male rats had 
more AVP mRNA-labeled cells in the BST (Figs. 1,2; ANOVA, 
F = 12.43, df = l/l 1, p < 0.01) and more grains per labeled 
cell (Fig. 3; ANOVA, F = 6.63, df = l/l 1, p < 0.05) than female 
rats. No significant differences were found in the labeling be- 
tween the left and right side of the brain. 
Effects of testosterone metabolites on A VP mRNA in males 
and females 
Overall, male rats had more AVP mRNA-labeled cells in the 
BST than female rats (ANOVA, F = 16.98, df = l/45, p < 
0.0005). In addition, the various hormonal treatments signifi- 
cantly affected the number oflabeled cells (ANOVA, F = 114.32, 
df = 3145, p < 000 1). These treatment effects, however, differed 
for males and females (Fig. 4; ANOVA, F = 8.43, df = 3/45, p 
< 0.0001). The post hoc Newman Keuls test indicated that 
E-treated males and females had significantly more AVP mRNA- 
labeled cells than males and females given empty tubing or 
tubing with DHT. E-treated males, however, showed signifi- 
cantly more labeled cells than E-treated females. Furthermore, 
if males were treated with E+DHT, they showed significantly 
more cells than males treated with E only. However, females 
treated with E+DHT did not show more cells than females 
treated with E only. No significant differences were found in the 
number of labeled cells between the left and right side of the 
brain. 
Since treatment with empty tubing or with DHT resulted in 
a loss of virtually all labeled cells in males as well as females, 
analysis of the number of grains over cells was done only in 
E-treated and E+DHT-treated animals. In these two groups, 
male rats showed more grains per labeled cell in the BST than 
females (Fig. 5; ANOVA, F = 14.93, df = l/23, p < 0.001). In 
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Figure 1. Photomicrographs of dark-field illuminated sections displaying cells labeled for AVP mRNA (arrows) in the BST of a female (A) and 
a male (B) treated with testosterone. The figure also displays labeled cells in the supraoptic nucleus (SON and the suprachiasmatic nucleus (SCN). 
Scale bar, 100 Frn. 
addition, E+DHT-treated rats had more grains per cell than 
E-treated rats (Figs. 5, 6; ANOVA, F = 6.46, df = l/23, p < 
0.05). Although the E+DHT treatment seemed to elevate the 
grain density specifically in males, the interaction of sex and 
treatment failed to reach significance (ANOVA, F = 3.82, df = 
l/23, p = 0.063). No significant differences were found in the 
H Male 
E3l Female 
Figure 2. Differences in the number of BST cells labeled for AVP 
mRNA in male (solidbars) and female rats (crosshatchedbars; ANOVA, 
p < 0.01). Bars indicate means t SEM. 
number of grains per cell between the left and right side of the 
brain. 
In the suprachiasmatic, supraoptic, and paraventricular nu- 
clei, the number of labeled cells and the grain density per cell 
could not be determined accurately. In the suprachiasmatic nu- 
cleus, counting cells and grains over cells was impossible because 
160 n Male 
Ix] Female 
0 
Figure 3. Differences in the number of grains per BST cell labeled for 
AVP mRNA in male (solid bars) and female rats (crosshatched bars; 
ANOVA, p < 0.05). Bars indicate means ? SEM. 
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Figure 4. Differences in the number of BST cells labeled for AVP 
mRNA in male (solid bars) and female rats (crosshatched bars) that were 
castrated (Control), or castrated and treated with dihydrotestosterone 
(DHT), estradiol, or a combination of estradiol and DHT (E+L)HT). 
These treatments had different effects in male and female rats (ANOVA, 
p < 0.0001). The Greek letters illustrate the results of the Newman 
Keuls post hoc test, which indicated that control and DHT-treated 
animals had fewer labeled cells than estradiol- or E+DHT-treated fe- 
males, which in turn had less cells than estradiol-treated males. E+DHT- 
treated males had more cells than any other group. Bars indicate means 
I SEM. 
the density of AVP cells caused the grains generated by different 
cells to overlap, while in the paraventricular and supraoptic 
nuclei the grain density per cell was too high to be measured 
reliably. None of these nuclei, however, showed any notable 
differences among the different hormonal conditions. 
Discussion 
If treated with similar amounts of testosterone, male rats show 
more AVP-ir cells in the BST and denser AVP-ir projections 
from the BST to areas such as the lateral septum and lateral 
habenular nucleus than female rats (De Vries and Al Shamma, 
1990). The results of the present study show that, under similar 
150 
1 I Male El Female 
Estradiol E+DHT 
Figure 5. Differences in the number of grains per BST cell labeled for 
AVP mRNA in male (solid bars) and female rats (crosshatched bars) 
that were treated with estradiol or a combination of estradiol and dihy- 
drotestosterone (E+DHT). 
25 0 Estradiol 
n E+DHT 
40 80 120 160 200 240 280 
40 80 120 160 200 240 280 
Number of Grains 
Figure 6. Frequency distributions of BST cells according to the density 
of their AVP mRNA labeling in female (top) and male rats (bottom) 
treated with estradiol (open bars) or estradiol and dihydrotestosterone 
(E + DHT, solid bars). 
hormonal conditions, males also show more BST cells that can 
be labeled for AVP mRNA and more labeling per cell than 
females. Furthermore, they show that there are sex differences 
in the responsiveness of individual BST cells to testosterone 
metabolites, in particular to DHT, which if given in combina- 
tion with E increased the number of AVP mRNA-labeled cells 
in males but not in females. The possibility that sex differences 
in hormone metabolism and in the levels and actions of estrogen 
and androgen receptors contribute to these differences will be 
discussed. 
A previous study comparing AVP mRNA labeling in three 
intact males and three intact females had suggested that males 
have more BST cells that can be labeled for AVP mRNA and 
more grains per labeled cell than females have (Miller et al., 
1989b). Since, in males, AVP mRNA labeling of individual BST 
cells reacts within a day to a reduction in gonadal hormone 
levels (Miller et al., 1992) the sex differences in AVP mRNA 
labeling reported by Miller et al. (1989b) could have been caused 
by sex differences in gonadal hormone levels. The present study, 
however, shows that sex differences in AVP mRNA labeling of 
BST cells remain present even if males and females are treated 
with similar amounts of testosterone, suggesting that sex dif- 
ferences in AVP mRNA labeling in intact animals cannot be 
explained merely by differences in circulating hormones. 
Sex differences in the interaction of gonadal hormones and 
AVP cells in the BST could have contributed to the sex differ- 
ences in AVP mRNA labeling observed in the present study. 
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For testosterone, this interaction appears to involve androgen 
as well as estrogen receptor-mediated mechanisms. Previously 
we had found that, in castrated male rats, E increases the levels 
of AVP immunoreactivity, but not to the same extent as tes- 
tosterone does. DHT, when given in a dose that restores the 
size of the seminal vesicles, does not influence AVP immuno- 
reactivity by itself, but when given in combination with E, it 
restores AVP immunoreactivity to levels reached after testos- 
terone treatment (De Vries et al., 1986). The present study shows 
that, in castrated males, the effects of E and DHT on AVP 
mRNA expression are similar to their effects on AVP immu- 
noreactivity. When given by itself, E increased the number of 
cells that were labeled for AVP mRNA as well as the level of 
AVP mRNA labeling per cell, while DHT when given by itself 
did not influence either. However, when given in combination 
with E, DHT did increase the number of AVP mRNA-labeled 
cells. Recently, we have found that local application of DHT in 
the brain of castrated rats can moderately elevate AVP mRNA 
labeling in the BST, suggesting that central actions of DHT may 
depend on its concentration (Brot et al., 1993). 
Since testosterone has to be aromatized into E before it can 
influence estrogen receptors (Lieberburg and McEwen, 1975; 
Naftolin et al., 1975) the higher levels of aromatase found in 
the BST of males (Roselli, 199 1) suggest that under similar 
testosterone treatment AVP-producing cells in the BST of males 
may be exposed to higher levels of E than similar cells in the 
BST of females. However, since males had still more AVP 
mRNA-labeled cells and more grains per labeled cell than fe- 
males after receiving similar E treatment, the sex differences in 
AVP mRNA labeling cannot be explained merely by sex dif- 
ferences in the conversion of testosterone into E. Rather, more 
BST cells in males respond to estrogen stimulation than in fe- 
males. The slightly higher proportion of labeling per cell in 
E-treated males than in E-treated females suggests that there are 
also sex differences in estrogen responsiveness of individual 
AVP-producing cells. 
Even more so than differences in estrogen responsiveness, sex 
differences in androgen responsiveness appear to contribute to 
sex differences in AVP-producing cells in the BST. When given 
in combination with E, DHT increased the number of AVP 
mRNA-labeled cells in males but not at all in females. These 
sex differences in steroid responsiveness may be based on sex 
differences in inputs that are responsive to gonadal hormones. 
There are, for example, sex differences in the substance P and 
cholecystokinin innervation of the BST, both of which are re- 
sponsive to testosterone and E (Malsbury and McKay, 1987; 
Simerly and Swanson, 1987; Micevych et al., 1988; Oro et al., 
1988). It is unknown, however, whether these inputs influence 
AVP production in the BST. Alternatively, sex differences in 
steroid responsiveness of AVP-producing cells in the BST may 
be based on differences in androgen and estrogen receptors with- 
in these cells, since virtually all them are immunoreactive for 
androgen and estrogen receptors (Axelson and Van Leeuwen, 
1990; Zhou et al., 1993). Although no sex differences have been 
found in the number of estrogen receptors in the BST (Brown 
et al., 1988, 1992) there are indeed sex differences in the number 
of androgen receptors associated with the cell nuclear fraction 
of the BST (Roselli, 199 1). Such sex differences in androgen 
receptors could explain why DHT acts on AVP mRNA labeling 
in males but not in females. 
In addition to sex differences in steroid-sensitive neuronal 
inputs or in steroid receptors levels, sex differences in the in- 
teractions of occupied gonadal steroid receptors may contribute 
to sex differences in AVP-producing cells in the BST. For ex- 
ample, since androgen enhances BST aromatase levels in males 
more than in females (Roselli et al., 1985a,b; Roselli, 1991) 
testosterone may enhance its own conversion into E and there- 
fore its actions on AVP mRNA expression in males more than 
in females. This particular androgen effect, however, cannot 
explain the sex differences in the effects of DHT on AVP mRNA 
in E-treated animals, since these animals were exposed to similar 
levels of E. Another possibility is that estrogen increases the 
responsiveness of individual cells to androgen in males more 
than in females. For example, E might prevent the metabolic 
inactivation of DHT in the brain (Sodersten, 1980). E might 
also increase the effectiveness of androgen receptors of AVP- 
producing cells by altering the duration of androgen receptor 
occupation, as has been observed in the preoptic area of male 
rats (Roselli and Fasasi, 1992). It is unknown, however, whether 
there are any sex differences in these actions of E. Finally, there 
may be sex differences in the interaction of gonadal steroid 
receptors and the AVP gene. Since there are no clearly recog- 
nizable androgen- and estrogen-responsive elements on the pro- 
moter region ofthe AVP gene (Adan and Burbach, 1992; Young, 
1992) the nature of this interaction is unclear. 
The sex differences found in the present study suggest that 
sexual differentiation of AVP projections of the BST entails a 
number of developmental decisions, among which a decision 
as to how many BST cells will express AVP and a decision on 
the efficacy of the mechanisms that mediate gonadal hormone 
effects on AVP gene expression in individual cells. A recent 
study suggests that these decisions depend on differences in the 
levels of gonadal hormones in the first weeks after birth (Wang 
et al., 1993). Interestingly, the latter study indicated that the 
decision as to how many cells will express AVP depends largely 
on hormonal differences in the second week after birth, whereas 
the decision as to how dense the AVP-ir fiber plexus will be- 
which may reflect absolute number as well as AVP content of 
individual fibers-depends on hormonal differences in the first 
as well as second week after birth. Such a discrepancy can indeed 
be explained by sexual differentiation of several cellular features 
that together contribute to the sexually dimorphic nature of 
AVP-producing cells in the BST. 
AVP projections of the BST are probably involved in social 
recognition memory, temperature regulation, and aggressive be- 
havior (Pittman et al., 1988; Bluthe et al., 1990; Koolhaas et 
al., 1990) and presumably in osmoregulation and reproductive 
functions (Epstein et al., 1983; Demotes-Mainard et al., 1986; 
Bamshad et al., 1993). Therefore, studying how steroid hor- 
mones influence these projections will help clarify how hor- 
mones induce and maintain the sex differences that have been 
found in several of these behaviors and functions (Dantzer and 
BluthC, 1992; De Vries et al., 1992). The extreme nature of the 
sex differences in, and hormonal effects upon, these projections 
will undoubtedly help in this pursuit. 
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